Skip to main content

Table 4 Multivariate logistic regression for colitis risk

From: Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

  IrAEa
Characteristic OR (95% CI) P
Race (Caucasian) 5.76 (2.03–16.36) 0.001
Cancer stage IV 0.09 (0.03–0.30) < 0.001
Cancer type (Melanoma) 1.96 (1.04–3.67) 0.037
ICPI agent   
 Ipilimumab + combination 2.23 (1.03–4.81) 0.041
 Nivolumab 0.39 (0.14–1.11) 0.079
Duration of ICPI treatment 0.99 (0.99–1.00) 0.049
  1. aRace, cancer stage, cancer type, ICPI agent, and duration of ICPI treatment were included in the multivariate logistic regression for colitis risk